 Hypertrophic cardiomyopathy (often called HCM) is a condition associated with the abnormal thickening of a portion or the entire heart muscle. It often affects young individuals and may not cause many symptoms but could result in sudden death.
Persons with HCM have unique needs and require specialized care over a wide range of medical expertise targeted towards relieving symptoms, preventing complications, and exploring surgical options. The recognition of the need for a specialized center to provide these services in a patient friendly, well-coordinated environment has led to the launch of the Johns Hopkins Hypertrophic Cardiomyopathy Clinic. Mission: The overall goal of this clinic is to offer patients with HCM and their families access to high quality clinical care supported by state of the art technology and research with a view to alleviate symptoms, prolong life and enhance the understanding of HCM, in a single center setting. We hope to achieve this goal by building a team dedicated to HCM care consisting of master clinicians, experts in multi-modality imaging, skilled interventional and surgical staff, specialists in genetic medicine and innovative researchers. The clinic staff hopes to improve the quality of life in HCM patients, provide education about the disease and to support research into better diagnosis techniques and treatments for HCM. Specific facilities available through the JHHCC include access to a clinic staffed by specialists in HCM management, echocardiography, magnetic resonance imaging and spectroscopy, genotyping and genetic counseling, non-invasive risk assessment for sudden death, defibrillator implantation, percutaneous alcohol septal ablation, surgical myectomy and cardiac transplantation. All patients and relatives are also offered voluntary enrollment in a variety of ongoing research projects. Ambulatory Clinic:
Theodore Abraham, MD, Lili Barouch, MD, Thomas Traill, MD, Edward Kasper, MD Evaluation of new and returning HCM patients Coordinate testing, risk assessment and initiation of medical therapy Assist patients and their referring physicians make decisions regarding interventional and surgical options for HCM Screen family members of HCM patients
Echocardiography/Non-invasive Hemodynamics:
Theodore Abraham, MD Standard transthoracic echocardiography Transesophageal echocardiography Exercise echocardiography Detailed hemodynamic assessment at rest and during provocation (Valsalva, Amyl Nitrite or exercise) Tissue Doppler and strain echocardiography to evaluate regional and global myocardial mechanics
Magnetic Resonance Imaging and Spectroscopy:
Katherine Wu, MD, David Bluemke, MD, Robert Weiss, MD Detailed morphologic and functional imaging via standard, tagged and contrast enhanced MR imaging Evaluation of novel disease markers by MR spectroscopy
Computed Tomography:
Joao A.C. Lima, MD Electrophysiology/Sudden Death Risk Assessment:
M. Roselle Abraham, MD, Joseph Marine, MD, Hugh G. Calkins, MD Hemodynamics/Cardiac Mechanics:
David A. Kass, MD Interventional Cardiology:
Jon Resar, MD Cardiac Surgery:
Luca Vricella, MD, Duke Cameron, MD, William Baumgartner, MD Medical Genetics:
Daniel Judge, MD, Nicole Johnson Genotyping Genetic counseling
Pediatrics:
Janet Scheel | 
